Cytochrome P450 inhibitor, Luliconazole, Purity ≥98%

Cat. No.: X24-08-YM389

Cytochrome P450 inhibitor, Luliconazole, Purity ≥98%

Synonym: 187164-19-8; NND 502; Lulicon; Luzu; NND-502; (2E-2-[(4R)-4-(2,4-Dichlorophenyl)-1,3-dithiolan-2-ylidene]-2-imidazol-1-ylacetonitrile

  • MDL: MFCD00953915
  • CAS Number: 187164-19-8
  • Compound CID: 3003141
Product Size
25 mg; 50 mg; 100 mg; 200 mg
Price
Datasheet
MSDS
Properties
Description
Luliconazole, soluble in DMSO and ethanol and insoluble in water, is an effective cell metabolism inhibitor, that has the ability to prevent the pathway of metabolism by inhibiting cytochrome P450.
Molecular Weight
354.28
Molecular Formula
C14H9Cl2N3S2
Form
Lyophilized powder
Purity
≥98%
Titer
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects
Solubility
In vitro: DMSO: 63 mg/mL (177.82 mM); Water: insoluble; Ethanol: 4 mg/mL (11.29 mM)
Stability
In its lyophilized form, the chemical remains stable for 36 months.
Quality Level
Research grade
Applications
Luliconazole is a metabolism inhibitor that can be studied extensively for its potential therapeutic applications in the treatment of fungal skin infections such as athlete’s foot, ringworm, and jock itch.
Storage
Store at -20ºC, and keep desiccated.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.